3 “Strong Buy” Biotech Stocks That Recently Went Public

This year has seen more than its share of successful IPOs – and some giant flops. The extremes should have been expected, in a year with a record number of new public offerings. The second quarter was the best quarter for IPO activity in the last four years, with 62 companies raising $25 billion – and bringing in an average return of 30%. The tech and biotech sectors led the way.IPO activity has continued in the second half, but with lesser returns. Tech startups have been underperforming the general market, returning about 5% against the S&P year-to-date average of 22%. …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.